Effect of disease-modifying treatment on coronavirus disease 2019 vaccination in patients with multiple sclerosis

被引：0
|
作者：
D'haeseleer, M. [1 ]
Van Remoortel, A. [1 ]
D'hooghe, M. [1 ]
Della Faille, L. [1 ]
Nagels, G. [2 ,3 ]
Van Schependom, J. [4 ]
机构：
[1] Natl Multiple Sclerose Centrum NMSC, Melsbroek, Belgium
[2] Vrije Univ Brussel VUB, Ctr Neurosci C4N, NEUR, Brussels, Belgium
[3] Vrije Univ Brussel VUB, AIMS, Brussels, Belgium
[4] Vrije Univ Brussel VUB, Dept Elect & Informat ETRO, Brussels, Belgium
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-172
引用
收藏
页码：429 / 430
页数：2
相关论文
共 50 条
  • [41] DISEASE-MODIFYING THERAPIES FOR MULTIPLE-SCLEROSIS
    CARTER, JL
    CNS DRUGS, 1995, 3 (02) : 99 - 114
  • [42] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Perumal, Jai
    Khan, Omar
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (03) : 256 - 263
  • [43] Multiple sclerosis disease-modifying therapy and pregnancy
    Miller, Aaron E.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : 715 - 716
  • [44] Discontinuing disease-modifying multiple sclerosis therapies
    Krysko, Kristen
    LANCET NEUROLOGY, 2023, 22 (07): : 543 - 545
  • [45] Update on disease-modifying therapies for multiple sclerosis
    Vargas, Diana L.
    Tyor, William R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (05) : 883 - 891
  • [46] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
    Tanuja Chitnis
    Neurotherapeutics, 2013, 10 : 89 - 96
  • [47] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Jai Perumal
    Omar Khan
    Current Treatment Options in Neurology, 2012, 14 : 256 - 263
  • [48] Multiple Sclerosis: Overview of Disease-Modifying Agents
    Finkelsztejn, Alessandro
    PERSPECTIVES IN MEDICINAL CHEMISTRY, 2014, 6 : 65 - 72
  • [49] Multiple Sclerosis, Disease-Modifying Therapies, and Infections
    Langer-Gould, Annette M.
    Smith, Jessica B.
    Gonzales, Edlin G.
    Piehl, Fredrik
    Li, Bonnie H.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (06):
  • [50] Use of Disease-Modifying Drugs in Multiple Sclerosis
    Wurzius, F. Q.
    Silva, C. B.
    de Vecino, M. A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 102 - 103
12345